PW 4103
Latest Information Update: 25 Apr 2007
At a glance
- Originator Penwest Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menstrual migraine
Most Recent Events
- 25 Apr 2007 Discontinued - Phase-I for Menstrual migraine in USA (unspecified route)
- 21 Oct 2003 Phase-I clinical trials in Menstrual migraine in USA (unspecified route)